Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Zoetis Inc. before investing.

In this article, we go over a few key elements for understanding Zoetis Inc.’s stock price such as:

• Zoetis Inc.’s current stock price and volume
• Why Zoetis Inc.’s stock price changed recently
• Upgrades and downgrades for ZTS from analysts
• ZTS’s stock price momentum as measured by its relative strength

About Zoetis Inc. (ZTS)

Before we jump into Zoetis Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.

Want to learn more about Zoetis Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Zoetis Inc..

Zoetis Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:02 PM, CST, Zoetis Inc.’s stock price was $77.290.

Zoetis Inc. is up 1.66% from its previous closing price of $76.030.

During the last market session, Zoetis Inc.’s stock traded between $74.910 and $77.520. Currently, there are approximately 422.10 million shares outstanding for Zoetis Inc..

Zoetis Inc.’s price-earnings (P/E) ratio is currently at 12.7, which is low compared to the Pharmaceuticals industry median of 20.5. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Zoetis Inc. Stock Price History

Zoetis Inc.’s (ZTS) price is currently up 7.56% so far this month.

During the month of July, Zoetis Inc.’s stock price has reached a high of $79.430 and a low of $72.110.

Over the last year, Zoetis Inc. has hit prices as high as $160.480 and as low as $71.470. Year to date, Zoetis Inc.’s stock is down 38.57%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Zoetis Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of July 31, 2026,, no analysts have changed their rating of Zoetis Inc.’s stock over the last month.

Additionally, you'll want to evaluate Zoetis Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Zoetis Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Zoetis Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Zoetis Inc. (ZTS) by visiting AAII Stock Evaluator.

Relative Price Strength of Zoetis Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Zoetis Inc. has a weighted four-quarter relative price strength of -20.90%, which translates to a Momentum Score of 12 and is considered to be Very Weak.

Want to learn more about how Zoetis Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Zoetis Inc. Stock Price: Bottom Line

As of July 31, 2026, Zoetis Inc.’s stock price is $77.290, which is up 1.66% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Zoetis Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.